| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.14 | 0.4 |